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The  renin–angiotensin  system  (RAS)  is  involved  in the cardiac  and  vascular  remodeling  associated  with
cardiovascular  diseases.  Angiotensin  (Ang)  II/AT1 axis is  known  to  promote  cardiac  hypertrophy  and  colla-
gen deposition.  In  contrast,  Ang-(1–7)/Mas  axis  opposes  Ang  II effects  in  the heart  producing  anti-trophic
and  anti-ﬁbrotic  effects.  Exercise  training  is known  to  induce  cardiac  remodeling  with  physiological
hypertrophy  without  ﬁbrosis.  We  hypothesize  that  cardiac  remodeling  induced  by  chronic  exercise
depends  on  the action  of Ang-(1–7)/Mas  axis.  Thus,  we  evaluated  the effect  of exercise  training  on  col-
lagen  deposition  and  RAS  components  in  the  heart  of  FVB/N  mice  lacking  Mas  receptor  (Mas-KO).  Male
wild-type  and Mas-KO  mice were  subjected  to  a moderate-intense  swimming  exercise  training  for  6
weeks. The  left ventricle  (LV) of  the  animals  was  sectioned  and  submitted  to qRT-PCR  and  histological
analysis.  Circulating  and  tissue  angiotensin  peptides  were  measured  by  RIA.  Sedentary  Mas-KO  presented
a higher  circulating  Ang  II/Ang-(1–7)  ratio  and  an  increased  ACE2  expression  in  the  LV.  Physical  training
induced  in  Mas-KO  and  WT  a similar  cardiac  hypertrophy  accompanied  by a  pronounced  increase  in
collagen  I and  III mRNA  expression.  Trained  Mas-KO  and  trained  WT  presented  increased  Ang-(1–7)  in
the blood.  However,  only  in  trained-WT  there  was  an  increase  in  Ang-(1–7)  in  the  LV.  In summary,  we
showed  that  deletion  of Mas in  FVB/N  mice  produced  an  unbalance  in RAS  equilibrium  increasing  Ang
II/AT1 arm  and  inducing  deleterious  cardiac  effects  as deposition  of  extracellular  matrix  proteins.  These
data indicate  that  Ang-(1–7)/Mas  axis  is an  important  counter-regulatory  mechanism  in  physical  training
ons.mediate  cardiac  adaptati
. Introduction
Cardiac hypertrophy is characterized by myocardic tissue
rowth as a consequence of an increase in cardiomyocyte pro-
ein synthesis and extracellular matrix deposition [2,12].  Cardiac
emodeling follows several diseases including arterial hyperten-
ion and valve stenosis (pathological hypertrophy) or as the result
f chronic exercise or pregnancy (physiological hypertrophy) [12].
athological cardiac hypertrophy is characterized by a thicken-
ng of the heart muscle which results in a decrease in the size
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ia  e Biofísica – ICB, Universidade Federal de Minas Gerais, Av. Antonio Carlos, 6627
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of the heart chambers, including the left and right ventricles
leading to diastolic dysfunction and later to systolic dysfunction
[2,12].
It is well established that the renin–angiotensin system (RAS)
plays an important role in the progression of cardiac remodel-
ing. The decrease in the overactivity of the angiotensin converting
enzyme (ACE)/angiotensin (Ang) II/Ang II type 1 receptor (AT1)
classical arm of RAS provides protection from pathological cardiac
hypertrophy and subsequent heart failure [12,38].  Ang II, through
its interactions with the AT1 receptor, has been demonstrated to
increase ﬁbroblast gene expression (including collagen), ﬁbroblast
density and proliferation, and myocyte hypertrophy, all of them are
hallmarks of myocardial ﬁbrosis and remodeling [12,14].  On the
other hand, ACE2 has been shown to have a high afﬁnity to hydrol-
yse Ang II [16], the pressor, hypertrophic/proﬁbrotic hormone of
Open access under the Elsevier OA license.the RAS, leading to the formation of Ang-(1–7), which presents
vasodilator, anti-trophic and antiﬁbrotic effects [6,9,13,23,25].
Thus, a balance between the activities of these two arms of the
RAS is important to keep cardiovascular homeostasis.
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Table  1
Body weight (BW), left ventricle weight and the ratio left ventricle weight/body weight in WT  and Mas  KO mice sedentary and submitted to exercise training (trained).
Groups (n) Initial body weight (g) Final body weight (g) Left ventricle weight (g) Left ventricle
(g) ×1000/BW (g)
WT (6) 30 ± 0.62 35.6 ± 0.84* 1.02 ± 0.07 2.86 ± 0.15
Trained  WT (11) 30 ± 0.61 31.0 ± 0.76# 1.09 ± 0.05 3.62 ± 0.11#
Mas-KO (7) 29 ± 1.07 30.0 ± 0.07# 0.92 ± 0.03 3.13 ± 0.07
Trained  Mas-KO (14) 29 ± 1.00 30.1 ± 1.13 1.18 ± 0.07 3.59 ± 0.11#
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* p < 0.05 in comparison to initial BW (Student t-test for paired observations).
# p < 0.05 in comparison to respective sedentary group (two-way ANOVA/followe
It has been well documented in the heart that Ang-(1–7)
resents several actions that oppose those of Ang II [36,38–40].
ost of the Ang-(1–7) actions are mediated by the Mas  recep-
or [41], which is present in the heart and have an important role
mproving heart function in isolated-heart reperfusion technique
19,37,39].  It was demonstrated that expression of an Ang-(1–7)-
roducing fusion protein produces cardioprotective effects in rats
39] and that chronic Mas-deﬁciency leads to impaired calcium
andling in cardiomyocytes revealing a key role for the Ang-
1–7)/Mas axis as a modulator of cardiomyocyte function [13,23].
ecently, Ferreira et al. [19] and Marques et al. [30] showed that
ncreased Ang-(1–7) in the heart attenuates isoproterenol-induced
ardiac ﬁbrosis in transgenic rats [19] and that an oral formulation
f Ang-(1–7) produces cardioprotective effects in rats with coro-
ary occlusion [30]. In addition, chronic infusion of Ang-(1–7) also
revents the cardiac ﬁbrosis produced in the DOCA-salt rat model
24,25]. More recently we have shown that lifetime overproduction
f Ang-(1–7) attenuates DOCA-salt hypertension-induced cardiac
ysfunction and remodeling [36]. Collectively, these ﬁndings led us
o the hypothesis that the Ang-(1–7)/Mas axis could have a role in
he physiological cardiac remodeling induced by chronic exercise,
hus the aim of the present study was to compare the alterations
n components of the RAS and extracellular matrix in the heart of
VB/N mice lacking Mas  receptor (Mas-KO) submitted to aerobic
wimming training.
. Materials and methods
.1. Animals
Twelve-weeks-old male FVB/N wild-type and FVB/N Mas-KO
ice were used. Mice were maintained at the Transgenic Animal
acilities of the Laboratory of Hypertension/INCT (Federal Uni-
ersity of Minas Gerais, Belo Horizonte, Brazil) and were treated
ccording to the international guidelines for animal care. The exper-
mental protocol was approved by the Ethics Committee in animal
xperimentation of the Federal University of Minas Gerais (pro-
ocol no. 009/08). Animals were divided into 4 groups: Mas-KO
edentary, Mas-KO trained, WT  sedentary, and WT  trained, and
aintained under controlled light and temperature conditions and
ad free access to water and standard diet.
.2. Physical training
We  deﬁne the intensity of 80% of maximum capacity for being
onsidered a moderate-intensity close to anaerobic threshold.
lthough we have not determined anaerobic threshold it has been
lready demonstrated that it usually occurs between 50% and 80%
f maximum capacity [31,45].  Furthermore, several studies have
uggested intensities near to the anaerobic threshold in animals
ith heart failure [27] and humans [5] to promote cardiovascular
apacity improvement.
Mas-KO and WT  FVBN mice were subjected to a swimming exer-
ise training with a workload attached to their tail correspondingonferroni post-test).
to 80% of the maximum load (ML) adjusted for each animal,
according to Evangelista et al. [17]. Initially the animals were
submitted to a 7 days of adaptation period which consisted of
swimming exercise sessions with a workload of 2% of body weight
attached to the tail with subsequent duration of 20, 40 and 60 min
in days 1–3, respectively. On the 4th day, they were submitted to
the maximum workload test. Days 5–7 animals swam with 80%
ML for 20, 40 and 60 min, respectively. This load was  then kept for
the ﬁrst two weeks of training. Mice swam for 6 weeks, 5 days per
week, once a day for 1 h, in water tanks with the water kept at 30 ◦C
with a thermostat to avoid thermal stress. The swimming training
was conducted between 9 and 11 am.  The maximum workload test
was repeated at the 1st day of the third and ﬁfth week of training
in order to adjust the workload to 80% ML throughout the train-
ing period. Constant monitoring was  given to ensure the safety of
the mice [17]. Sedentary mice were placed in water tanks for 5 min
daily to mimic  the water stress.
2.3. Tissue and blood collection
Twenty four hours after the last session of swimming exercise
mice were killed by decapitation and the trunk blood was  rapidly
collected into chilled polypropylene tubes containing guanidine
thiocyanate and centrifuged, as described previously [42]. Simulta-
neously, the heart was excised and dissected onto ice. Left ventricle
(LV) was  weighted and divided in three transversal portions: base,
median and apex. Base and apex were snapped frozen and the
median segment of LV was  processed for histology. Total blood and
LV segments were kept in −80 ◦C until assayed.
2.4. Reverse transcription and real-time PCR
Total RNA from the apex segment of the LV was prepared using
TRIzol reagent (Invitrogen, San Diego, CA), treated with DNAse, and
reverse transcribed with MML-V (Moloney murine leukemia virus)
(Invitrogen) [43]. The endogenous HPRT – hypoxanthine guanine
phosphoribosyltransferase (internal control), collagen I, collagen
III, ﬁbronectin, angiotensin converting enzyme (ACE), ACE 2 and
AT1 receptor cDNA were ampliﬁed using speciﬁc primers (Table 1)
and SYBR green reagent (Applied Biosystems) in an ABI Prism
7000 platform (Applied Biosystems). The relative comparative CT
method of Livak and Schmittgen was  applied to compare gene
expression levels between groups, using the equation 2−CT [29].
2.5. Histological analysis
Median LV segment was  ﬁxed in Bouin solution (4% at 4 ◦C) for
24 h, washed with water and maintained in 70% ethanol overnight.
Subsequently, tissue was  embedded in parafﬁn, sectioned (5 m)
and stained with hematoxylin and eosin. Images from 3 slides of
each animal were captured and cardiac ﬁbers from at least 150
cells of each group were measured using LC Evolution/Olympus
Bx50 using a 40× objective. Cardiomyocytes were analyzed only
from longitudinal ﬁbers with well deﬁned central nucleus.
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.6. Ang-(1–7) and Ang II measurements
The segment from the base of the LV was homogenized in
 mol/L of guanidine thiocyanate/1% triﬂuoroacetic acid (vol/vol;
 ml  for each tissue) in water and then processed as described
reviously [8,36].  Blood and LV peptides were extracted onto bond-
lut phenylsilane cartridges (Varian) and Ang-(1–7) and Ang II
mmunoreactivity (ir) was measured by radioimmunoassay, as
escribed previously by Botelho et al. [7].
.7. Statistical analysis
Data are expressed as mean ± SE. Comparisons between two
bservations in the same animal or two groups were performed by
tudent t-test paired or not paired, respectively. Differences among
ore than 2 groups were assessed by two-way ANOVA followed
y the Bonferroni test. The statistical analysis was performed with
raphPad Prism software (version 4.0), and the level of signiﬁcance
as set at p < 0.05.
. Results
.1. Comparison between sedentary Mas-KO and WT  mice
As observed in Table 1, sedentary WT  mice gained weight dur-
ng the 6 weeks period (36.0 ± 0.8 g) in comparison to their initial
eight (30.0 ± 0.6 g), while sedentary Mas-KO mice did not signif-
cantly alter body weight (Table 1). In the sedentary group, Ang
I levels in the blood of Mas-KO (141 ± 38 pg/ml; Fig. 1) were not
igniﬁcantly different from WT  (105 ± 8 pg/ml; Fig. 1). However,
ng-(1–7) was signiﬁcantly lower in Mas-KO (41 ± 6 pg/ml) as com-
ared to WT  (137 ± 9 pg/ml; Fig. 1). The ratio of circulating Ang
I/Ang-(1–7) in the blood of Mas-KO mice was 3.5 while in WT  it
as 0.7, which pointed out for a strong unbalance in circulating
AS with a predominance of Ang II in Mas-KO. No differences were
bserved in the concentrations of angiotensin peptides in the LVry and trained Mas-KO and WT mice as determined by RIA. Statistically signiﬁcant
trol and #p < 0.05 in comparison to WT (two-way ANOVA followed by Bonferroni
[Ang II: 6 ± 2 pg/mg vs 5 ± 1 pg/mg in WT;  Ang-(1–7): 33 ± 6 pg/mg
vs 34 ± 4 pg/mg in WT;  Fig. 1].
Analysis of mRNA expression in the LV showed a higher expres-
sion of ACE2 in Mas-KO mice (3.98 ± 0.68 AU vs 1.0 ± 0.16 AU in WT;
Fig. 2), accompanied by no difference in the expression of ACE or
AT1 receptor in comparison to WT  (Fig. 2). In addition, while colla-
gen I and ﬁbronectin mRNA expression were not different, collagen
III expression was signiﬁcantly lower in Mas-KO (0.37 ± 0.02 AU vs
1.0 ± 0.1 AU in WT;  Fig. 3). No differences were observed in body
weight, cardiomyocyte diameter and LV weight in Mas-KO in com-
parison to WT  sedentary animals (Table 1).
3.2. Effect of swimming training on blood and LV angiotensin
components in Mas-KO mice
Six weeks of physical training did not change the body weight of
Mas  KO or WT  mice compared with pre-exercise values (Table 1).
Physical training induced similar increase (∼10%) in cardiomyocyte
diameter in Mas-KO (11 ± 0.2 m vs 10 ± 0.2 m in sedentary Mas-
KO; Fig. 4) and in WT  (10 ± 0.2 m vs 9 ± 0.2 in sedentary WT;
Fig. 4). The change in cardiomyocyte diameter was accompanied
by an increase in mRNA expression of collagen I, collagen III and
ﬁbronectin in Mas-KO mice. In WT  mice there was  a tendency to
increase collagen I, however only ﬁbronectin expression was sig-
niﬁcantly augmented (two way  ANOVA; Fig. 3).
Physical training induced signiﬁcant increase in Ang-(1–7) in
the blood of Mas-KO (491 ± 53 pg/ml vs 41 ± 6 pg/ml in sedentary
Mas-KO; Fig. 1) and in WT  mice (244 ± 33 pg/ml vs 137 ± 9 pg/ml
in sedentary WT;  Fig. 1). As seen in Fig. 1, this increase was higher
in trained Mas-KO (491 ± 53 pg/ml) in comparison to trained WT
(244 ± 33 pg/ml). Interestingly, there was an increase in Ang-(1–7)
levels (∼2 fold) in the LV only in trained WT  (80 ± 16 pg/ml vs
34 ± 4 pg/ml in sedentary WT). In contrast, trained Mas-KO pre-
sented an increase in Ang II levels in the blood (331 ± 73 pg/ml
vs 141 ± 38 pg/ml in sedentary Mas-KO; Fig. 1) and in the LV
(62 ± 10 pg/mg protein vs 4.2 ± 0.61 pg/mg protein in sedentary
Mas-KO; Fig. 1). No changes in Ang II levels were observed in trained
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T  (Fig. 1). The differential changes in circulating and LV levels of
ngiotensin peptides after exercise training resulted in a reduction
f the ratio Ang II/Ang-(1–7) in the blood of WT  (0.4 vs 0.7 in seden-
ary WT)  and Mas-KO (0.7 vs 3.5 in sedentary Mas-KO). In addition,
xercise training induced a great decrease in Ang II/Ang-(1–7) ratio
n the LV of WT  mice (0.07 vs 1.42 in sedentary). However, in
ontrast to WT,  exercise training in Mas-KO did not change Ang
ig. 3. Left ventricle (LV) mRNA expression of extracellular matrix proteins in sedentary
igniﬁcant differences between the groups are indicated as *p < 0.05 in comparison to se
onferroni post-test).and trained Mas-KO and WT mice. Data are presented as means ± SE. Statistically
ntary and #p < 0.05 in comparison to WT  (two-way ANOVA followed by Bonferroni
II/Ang-(1–7) ratio in the LV (1.71 vs 1.42 in sedentary mice). Thus,
although in the blood there was a change toward a reduction in
Ang II relative to Ang-(1–7), in the LV Ang II levels were higher
than Ang-(1–7) levels.
Physical training induced a higher decrease (90%) in ACE mRNA
expression in WT  mice (0.003 ± 0.0007 AU vs 1 ± 0.3 AU in seden-
tary WT;  Fig. 2) accompanied by a 3 fold increase in AT1 receptor
 and trained Mas-KO and WT mice. Data are presented as means ± SE. Statistically
dentary control and #p < 0.05 in comparison to WT (two-way ANOVA followed by
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xpression (3 ± 0.8 AU vs 1 ± 0.4 AU in control WT;  Fig. 2) and a
0% decrease in ACE2 expression (Fig. 2). No signiﬁcant alteration
as induced by exercise in the expression of ACE, ACE2 or AT1 in
as-KO mice (Fig. 2). Thus, comparing the ratio ACE/ACE2 in WT
ice, we observed that exercise training in WT  mice induced a great
eduction in ACE/ACE2 balance (0.001 vs 1.0 compared to seden-
ary WT  mice). However, in trained Mas-KO exercise there was an
ncrease in ACE/ACE2 ratio (0.10 vs 0.03 in sedentary Mas-KO mice).
hese changes will favor Ang-(1–7) accumulation in WT,  but not in
as-KO mice, in which the accumulation of Ang II is being favored.
. Discussion
The main result of the present study was the observation that
 weeks of swimming training in FVB/N mice lacking Mas  induced
ardiac hypertrophy which was associated to an increase in col-
agen I and III mRNA expression. The increase in collagen may  be
elated to an inversion of the balance between Ang II and Ang-(1–7)
ctions in the heart of Mas-KO, favoring a stronger and unopposed
nﬂuence of Ang II. Further, our data showed that the lack of Mas
eceptor produces a reduction in circulating levels of Ang-(1–7)
esulting in an systemic unbalance of Ang II/Ang-(1–7) relationship.The role of the RAS on the development of cardiovascular sys-
em hypertrophy has been well studied. It is well documented that
ng II acting through AT1 receptor produces a hypertrophic and
roﬁbrotic effect in heart [12,14]. Different studies have shownT  mice (B), trained Mas-KO mice (C) and sedentary Mas-KO mice (D). Sections of
cally signiﬁcant differences between the groups are indicated as *p < 0.05 (two-way
that ACE2 and Ang-(1–7) exert an important role on cardiovascular
homoeostasis producing vasodilatation in different territories and
cardiac/vascular antiﬁbrotic and antitrophic effects [6,9,36] that
oppose those of Ang II actions. In addition, Ang-(1–7) inhibits car-
diac myocytes growth through activation of the Mas  receptor [13]
preventing pathological remodeling through NO/cGMP dependent
pathway [13,23].  The present ﬁndings reinforce the importance
of Ang-(1–7)/Mas axis in cardiovascular hypertrophy by showing
that Mas  deletion induces deleterious effects in the heart of trained
mice. Mas-KO trained animals presented an increased expression of
matrix proteins probably due to the lack of Mas-mediated actions
of Ang-(1–7), associated to an increase in Ang II and AT1 levels in
the heart.
Previous studies using echocardiography have shown that
Mas  deﬁcient mice present an impaired heart function with
lower systolic tension and lower heart rate accompanied by a
signiﬁcantly decreased fractional shortening and posterior wall
thickness in systole, and a higher left ventricle end-systolic and
end-diastolic dimensions, indicating a markedly lower global
ventricular function [37]. An impaired cardiac function during
ischemia/reperfusion was also shown in Mas-KO mice [9].  These
data indicate that Ang-(1–7)/Mas is importantly related to a normal
cardiac function [39,40]. These data indicate that Ang-(1–7)/Mas is
importantly related to a normal cardiac function. Although cardiac
dynamics data are not provided, our results advances this hypoth-
esis by showing that exercise in Mas-KO mice induces pre-ﬁbrotic
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ffects probably due to an exaggerated and unopposed effect of Ang
I. In addition, these data suggest that exercise may  not improve
ardiac function in Mas-KO mice. Future studies should address
he impact of these changes in the cardiac dynamics of animals
ubmitted to physical exercise.
Swimming training induced similar hypertrophy in Mas-KO and
T mice, since cardiomyocytes diameter and relative LV weight
ere increased approximately by the same proportion (10%) in
oth groups. In a previous study, we showed that Mas  deﬁcient
57/BL6 mice presented altered extracellular matrix components
ith an increase in collagen and ﬁbronectin expression in LV,
uggesting an antiﬁbrotic action of Ang-(1–7)/Mas axis [37]. Our
resent data advanced these observations by showing that Mas-KO
ice submitted to moderate-intense physical training presented
n increased expression of collagen I and collagen III compared to
rained WT  or sedentary Mas-KO mice. These data suggest that
ng-(1–7) through Mas  may  exert a compensatory mechanism
ounteracting an increase in extracellular matrix after chronic exer-
ise.
One can argue that the LV hypertrophy would be higher in Mas-
O mice submitted to exercise than in the controls. Nevertheless,
e have shown that Mas-KO mice have an increased collagen depo-
ition after physical exercise, which is probably independent of
he hypertrophy. Other studies have shown that cardiac hypertro-
hy and ﬁbrosis may  not be linked phenomena and the signaling
athways leading to the hypertrophic and proﬁbrotic response of
he heart to similar stimulus are distinct [10,11,35].  In the present
tudy, although the hypertrophy to exercise was similar in WT  and
as-KO, our data show that an increase in Ang II, without Ang-
1–7) action, may  lead to pre-ﬁbrotic lesions in the heart of mice
ubmitted to exercise. Exercise cardiac hypertrophy is considered
o be an adaptive beneﬁcial physiological phenomenon triggered
y the cardiac metabolic demand and hemodynamic changes that
ccurs during repeated exercise bout [18,21,46–48]. Further, these
timuli may  not be directly affected by RAS unbalance, at least
n mice and in the protocol and time point of our study. Even in
athological hypertrophy induced, for instance, by hypertension
issociation between hypertrophy and pre-ﬁbrotic lesions in the
eart are observed. Previous studies in the DOCA-salt hypertensive
odel have shown that chronic Ang-(1–7) treatment prevented
ardiac ﬁbrosis but not hypertrophy, and the Ang-(1–7) infusion
ad no effect on the DOCA-salt hypertension or blood pressure
esponses to intravenous Ang II [24,25]. Recently, we have shown
36] that transgenic rats with systemic overexpression of Ang-(1–7)
resented attenuated hypertension and cardiac hypertrophy and
brosis when subjected to DOCA-salt hypertension model. Further,
n this study these effects were accompanied by a remarkable (∼4
imes) increase in Ang-(1–7) in the left ventricle. Thus, we believe
hat the different results on cardiac hypertrophy vs ﬁbrosis vs high
lood pressure among these studies may  be related to levels of Ang-
1–7) that can be achieved locally in the heart, i.e., a direct cardiac
rotective action of Ang-(1–7) in the heart (supported by studies in
ivo, as cited above, and in cultured ﬁbroblasts and myocytes), com-
letely independent from the arterial pressure regulatory functions
f Ang-(1–7).
The extracellular matrix deposition is regulated by Ang II in dif-
erent pathologies as demonstrated in several studies [12,14,49].
ng II controls collagen and ﬁbronectin synthesis in cardiac dys-
unction [44] and Ang-(1–7)/Mas axis can reduce the hypertrophic
nd proﬁbrotic effects induced by Ang II [38,40,49].  In addition,
everal studies showed that chronic treatment with AT1 antago-
ists or ACE inhibitors can reverse or attenuate ﬁbrosis in the heart
28,44]. Different models of exercise training and/or Ang II recep-
or blockade post myocardial infarction show reduction in matrix
etalloproteinase 1 expression and mitigates the expressions of
CE and AT1 in rats [44]. These effects can be partially attributed todes 38 (2012) 54–61 59
an increase in Ang-(1–7) levels that is induced by AT1 blockade or
ACE inhibition, since chronic administration of these drugs increase
Ang-(1–7) production [33]. Our data reinforce the hypothesis that
Ang-(1–7)/Mas axis produces antiﬁbrotic effects in the heart and,
further, suggest that the absence of Ang-(1–7)/Mas action can lead
to collagen deposition after physical training.
In the present study we  observed that in sedentary animals,
circulating Ang-(1–7) was  decreased in Mas-KO compared to WT,
resulting in a much higher Ang II/Ang-(1–7) ratio. Interestingly,
in both trained WT  and Mas-KO mice an important increase
in circulating Ang-(1–7) was  observed. The increase in Ang-
(1–7) post-training may  be related to cardioprotection induced
by exercise through vasodilatation increase, autonomic function
improvement and nitric oxide release. However, the LV level of
Ang-(1–7) was increased only in trained WT  mice. This result is in
keeping with the study of Filho et al. [20] that showed that sponta-
neously hypertensive rats subjected to physical training presented
selective increase in Ang-(1–7) level and Mas  receptor expression
in the heart, suggesting that the beneﬁcial effect induced by swim-
ming training in hypertensive rats might include an augmentation
of Ang-(1–7)/Mas axis activation in the heart. Further, our data sug-
gest that the lack of Mas  may impair the increase in Ang-(1–7) levels
in the heart pointing to a speciﬁc tissue control effect of Mas  recep-
tor in the heart [20]. One possibility, which was  previously shown
for Ang II [32,34], is that the increase in Ang-(1–7) levels in the LV
could be due to an uptake of the peptide from the circulation, and
Mas  receptor deﬁciency impair, at least in part, the cardiac accu-
mulation of Ang-(1–7). The increased levels of Ang-(1–7) in the
circulation and the decreased levels in the heart in Mas-KO mice
are in keeping with this hypothesis. Further, our present data sug-
gest that this putative mechanism may  depend on an interaction of
Ang-(1–7) with its receptor Mas.
Another possibility is that Ang-(1–7) acting though Mas would
alter the expression of the main RAS enzymes, ACE and ACE2, favor-
ing the degradation of Ang II and the buildup of Ang-(1–7). In fact,
while trained WT rats presented a decrease in ACE and ACE2 expres-
sion, no alteration was  observed in trained Mas-KO mice. In line
with this observation, ACE2 expression in sedentary Mas-KO was
increased in the heart. Studies have shown that Ang II can reduce
ACE2 expression in cardiomyocytes in culture and Ang-(1–7) has
no direct effect [26]. In astrocytes, Ang-(1–7) had no direct effect
but attenuated the Ang II inhibitory effect on ACE2 expression [22].
The cardiac effects observed in Mas-KO mice cannot be
attributable only to the lack of Ang-(1–7) action, since circulating
and cardiac Ang II were augmented in Mas-KO, but not in trained
WT  mice, which certainly contributed to worsen the equilibrium of
the RAS peptides balance in the heart. In Mas-KO mice there was
smaller decrease in ACE accompanied by no change in ACE2 expres-
sion, which resulted in an increased ratio ACE/ACE2. This effect is
in keeping with the increased levels of Ang II in the hearts of Mas-
KO mice. Interestingly, based on the studies of Ishiyama et al. [26]
we could expect that cardiac ACE2 would decrease in Mas-KO mice
due to the increase in Ang II in the LV. Future studies will be neces-
sary to further clarify the effect of Ang II and Ang-(1–7) on the RAS
enzyme, ACE and ACE2, in the mouse heart.
In trained WT mice we  observed a decrease in LV ACE (∼90%)
and ACE2 (∼70%) expression resulting in a high decrease in the ratio
ACE/ACE2 which will favor Ang-(1–7) building up in the heart. It is
well known the ACE breaks down Ang-(1–7) producing an inactive
peptide, Ang-(1–5) [1].  Thus, the relative higher decrease in ACE in
comparison to ACE2 will decrease the degradation of Ang-(1–7). We
have previously observed that in DOCA salt-induced hypertension
in transgenic rats, that presents an overexpression of Ang-(1–7) in
the circulation, there was  an increase in Ang-(1–7) in the heart that
was accompanied by a decrease in ACE and ACE2 mRNA expres-
sion [36]. Taken together, these data support our hypothesis of a
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odulatory role for Ang-(1–7) in the expression of ACE and ACE2
n the heart.
Interestingly, the expression of AT1 mRNA was higher in trained
T mice, which may  reﬂect an upregulation of the receptor in
esponse to the large relative reduction of Ang II [3,4]. In addition,
t is known that AT1 participates in the cardiac hypertrophic mech-
nisms independent of alterations in heart Ang II levels [15,50].
nother possible mechanism can involve direct activation of AT1
y cardiomyocyte stretch as demonstrated in previous studies [49].
. Conclusion
In summary, the results obtained in the present study show
hat genetic deletion of Mas  in FVB/N mice produced an unbal-
nce in RAS equilibrium increasing Ang II/AT1 arm activation in
he heart. An important ﬁnding of the present study was  to show
hat moderate-intense swimming training in Mas-KO mice induced
ardiac hypertrophy accompanied by a pronounced increase in col-
agen I and III mRNA expression. Unlike trained WT  mice, where
here was a marked increase in Ang-(1–7) levels in the LV, trained
as-KO presented a pronounced increased in Ang II. Thus, the car-
iac pro-ﬁbrotic effect observed in Mas-KO after training maybe
elated to a stronger and unopposed inﬂuence of Ang II. These
ata show that Ang-(1–7) acting through Mas  receptor produces
n important counter-regulatory role in physical training medi-
te cardiac adaptations. These data indicate that pharmacological
trategies that lead to an increase in Ang-(1–7) or another Mas
eceptor agonist in the heart may  be an additional important mech-
nism to oppose Ang II induced collagen deposition in patients with
ardiovascular disease.
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